Charles Campbell, M.D.
Ophthalmology Physician in Quakertown, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Charles Campbell, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 672 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 672
- Part D claims, 2024
- 75%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Charles Campbell, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1295822062), first enumerated 10/05/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 672 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$157.92 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Charles Campbell, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1295822062 · Ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1295822062
- ENUM-LEGACY 2006
- TAX-MID 22K Ophthalmology Physician
- MIPS-NEUTRAL 75/100
- RX-LIGHT 672
- BOOK-LIGHT 1,052 in Pennsylvania
- PHOTO-ENUM Ronald Blitzer · 2006
Charles Campbell, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
672 ≥ 68th percentile 68% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Charles Campbell, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Charles Campbell, M.D.?
CMS neutral score, not measuredPrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Pennsylvania
How Ophthalmology Physician compares to other specialties among Pennsylvania providers
Ophthalmology Physician ranks #50 among Pennsylvania's specialties (0.4% of in-state providers)
Each bar is a specialty's share of the Pennsylvania provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1295822062 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Charles Campbell, M.D.'s current license status, disciplinary history, and board certifications with the Pennsylvania State Board of Medicine in Pennsylvania before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1295822062 is the unique 10-digit identifier CMS uses to link Campbell across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Charles Campbell, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$158
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Charles Campbell, M.D.. To verify Charles Campbell, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
25% brand-name claims vs 75% generic, on 672 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,287.867
- Total Day Supply
- 37,145
- Brand vs Generic
- 25% brand / 75% generic
- Brand Drug Cost
- $65K
- Generic Drug Cost
- $19K
Patient Demographics
- Average Patient Age
- 78.9 years
- Avg HCC Risk Score
- 1.20
- Gender Split
- 57% female / 43% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Charles Campbell, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
263 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
133 claims
- Lumigan 51
Lumigan
51 claims
- Timolol Maleate 39
Timolol Maleate
39 claims
- Prednisolone Acetate 37
Prednisolone Acetate
37 claims
- Restasis 35
Restasis
35 claims
- Cyclosporine 22
Cyclosporine
22 claims
- Brimonidine Tartra… 19
Brimonidine Tartrate-Timolol
19 claims
| Drug | Claims |
|---|---|
| Latanoprost | 263 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 133 |
| Lumigan Bimatoprost | 51 |
| Timolol Maleate | 39 |
| Prednisolone Acetate | 37 |
| Restasis Cyclosporine | 35 |
| Cyclosporine | 22 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 19 |
| Travoprost | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Charles Campbell, M.D. fits within the Ophthalmology Physician landscape nationally.
Charles Campbell, M.D.'s 672 claims are below the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Campbell, both outside Pennsylvania so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Campbell.
One of 1,052 Ophthalmology Physician providers enrolled in Pennsylvania, 5 are shown here.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Charles Campbell, M.D.'s specialty? ▼
How much does Charles Campbell, M.D. prescribe under Medicare Part D? ▼
What is Charles Campbell, M.D.'s Medicare quality score? ▼
Where is Charles Campbell, M.D. located? ▼
What is Charles Campbell, M.D.'s NPI number? ▼
Does Charles Campbell, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Charles Campbell, M.D. prescribe most often? ▼
Does Charles Campbell, M.D. accept Medicare? ▼
How can I verify Charles Campbell, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.